News Search Results

Displaying Results 301-325 of 649 "ophthalmology"

Sep 16, 2025, 01:00 ET Happiest Health Announces Ethics in Healthcare Summit 2025: A Platform for Trust, Transparency & Reform

individuals to take charge of their health. The Healthcare Services (HCS) division offers Dental services, with more disciplines like ENT, Ophthalmology, Dermatology and Orthopaedics being added soon. Our Wellness division provides Ayurveda, Physiotherapy, and Yoga clinics with a Mental Health

More news about: Happiest Health Systems Pvt LTD


Sep 15, 2025, 21:00 ET Innovent to Present Multiple R&D Results of General Biomedicine Pipeline at the 34th EADV Congress 2025

that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major disease areas, announces that it will present multiple research results at the 34th European Academy of Dermatology and Venereology

More news about: Innovent Biologics


Sep 15, 2025, 14:04 ET Global Busbar Market Driven by Rising Demand for Energy Efficiency and Power Distribution Solutions - Market Research Intellect

Lasers Market is categorized based on Product (Diode Lasers, CO₂ Lasers, Er:YAG Lasers, Nd:YAG Lasers, Alexandrite Lasers) and Application (Ophthalmology, Dermatology & Aesthetics, Dentistry, Urology, Gynecology) and geographical regions

More news about: Market Research Intellect


Sep 15, 2025, 07:00 ET New data for Kodiak's KSI-101 from the APEX study reinforce its clinically meaningful vision gains and rapid retinal drying in macular edema secondary to inflammation (MESI)

Meeting in Chicago, Illinois. Dr. Charles Wykoff, MD, PhD, Deputy Chair of Ophthalmology, Blanton Eye Institute, presented continuing data from the three-arm, open-label Phase 1b APEX study of KSI-101 for

More news about: Kodiak Sciences Inc.


Sep 15, 2025, 01:54 ET Mann Eye Institute Welcomes Internationally Renowned Ophthalmic Oncology Expert Dr. Bita Esmaeli

2024, she served as a tenured Professor of Ophthalmology at The University of Texas M. D. Anderson Cancer Center in Houston, where she held leadership roles including Chief of the Section of Ophthalmology from 1998 to 2004 and Ophthalmic Plastic

More news about: Mann Eye Institute


Sep 12, 2025, 09:04 ET Haag-Streit USA announces US launch of Elara 900 and Refractor 900

American Academy of Ophthalmology (AAO) annual meeting in October.

More news about: Haag-Streit USA


Sep 11, 2025, 13:22 ET Why Ophthalmology Surgery Centers Are Choosing NorthStar for Anesthesia Partnership

IRVING, Texas, Sept. 11, 2025 /PRNewswire/ -- Ophthalmology surgery centers nationwide are increasingly choosing NorthStar Anesthesia as their trusted partner for anesthesia care. With a model purpose-built

More news about: NorthStar Anesthesia


Sep 11, 2025, 01:12 ET PRIVACY ALERT: Retina Group of Florida Under Investigation for Data Breach of 152,691 Patient Records

of 152,691 patients of Retina Group of Florida. Retina Group of Florida is an ophthalmology practice that operates 23 retina clinics in East, South and Southwest Gulf Coast Florida.

More news about: Schubert Jonckheer & Kolbe LLP


Sep 10, 2025, 09:00 ET Luminopia Partners with Pokémon to Expand Its Curated Content Library for Pediatric Amblyopia Patients

results were published in Ophthalmology, leading to the initial FDA approval for patients aged 4 to 7 years. Based on the robust real-world evidence collected through the PUPiL Registry,

More news about: Luminopia


Sep 09, 2025, 17:31 ET Open-Angle Glaucoma Market Outlook Brightens as Emerging Therapies Reshape Treatment Paradigms | DelveInsight

public health concern. Greater disease detection & screening efforts Improved screening programs, wider use of OCT and tele-ophthalmology, and growing awareness mean more early diagnoses, which increases lifetime treatment uptake (drops, combination therapy, procedures). This enlarges

More news about: DelveInsight Business Research, LLP


Sep 09, 2025, 10:01 ET Next Generation Antibody Therapeutics Market Size will Hit $22.88 Billion by 2033, Fueled by Breakthroughs in Oncology and AI-Driven Drug Design | DataM Intelligence

and patient compliance. Antibody fragments and scaffolds, although comparatively smaller in size, showcased high growth potential, especially in ophthalmology and inflammatory diseases, contributing over US$ 0.9 billion in 2024. By Therapeutic Area Oncology

More news about: DataM Intelligence 4 Market Research LLP


Sep 09, 2025, 08:15 ET DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Return Capital to the Shareholders

If InMode is likely to experience higher future sales – as it continues to innovate, taking current technology into new areas such as urology and ophthalmology and invests in R&D, while maintaining SG&A at a high level, waiting for the market to recover – buybacks are the right tool to generate

More news about: DOMA Perpetual


Sep 08, 2025, 11:00 ET ABMS Announces a Record Number of ABMS Scholars for the 2025-2026 Cohort

ABMS Member Board participants include: Allergy and Immunology, Dermatology, Emergency Medicine, Internal Medicine, Obstetrics and Gynecology, Ophthalmology, Orthopaedic Surgery, Pediatrics, Physical Medicine and Rehabilitation, Radiology, Surgery, and Urology. This ABMS Scholars cohort will begin

More news about: American Board of Medical Specialties


Sep 07, 2025, 20:30 ET Innovent Announces Phase 2 Results of Tigulixostat (IBI128, XOI) in Gout Patients were Published at the 27th Asia-Pacific League of Associations for Rheumatology Congress

that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major disease areas, announced that the results of the Phase 2 clinical study of the xanthine oxidase inhibitor (XOI) tigulixostat (R&D

More news about: Innovent Biologics


Sep 03, 2025, 11:55 ET VirtuaLens Launches Immersive Virtual Reality IOL Simulator, Transforming Cataract Patient Education and Lens Selection

Cataract surgery is among the most frequently performed and life-changing procedures in ophthalmology, with millions of cases carried out annually globally, including several million in the United States alone. Despite

More news about: VirtuaLens


Sep 03, 2025, 10:45 ET Ophthalmic Imaging Market worth US$3.84 billion by 2030 with 6.3% CAGR | MarketsandMarkets™

major restraints, limiting accessibility and implementation, especially in low-resource settings. Key opportunities include the expansion of tele-ophthalmology, increased healthcare investments in emerging economies, and the growing need for early, accurate detection of vision-threatening conditions.

More news about: MarketsandMarkets


Sep 03, 2025, 10:15 ET Ophthalmic Devices Market Surges to USD 100.2 Billion by 2033, Propelled by 6.4% CAGR - Verified Market Reports®

System Market Size By Product Type (Softwares, Hardware), By Application (Retinal Imaging, Anterior Segment Imaging), By End-User (Hospitals, Ophthalmology Clinics), By Deployment Mode (Cloud-based Solutions, On-premise Solutions), By Technology Type (Artificial Intelligence, Machine Learning), By Geographic

More news about: Verified Market Reports


Sep 03, 2025, 05:30 ET Acer Medical Unveils aiMed Ahead of IFA 2025, Showcasing the Future of AI in Healthcare

secure cloud-based architecture further ensures data protection. Acer Medical also provides the VeriSee platform, an AI-assisted ophthalmology analysis platform. It can integrate multiple existing and new AI modules, allowing doctors to select and use them based on different clinical needs.

More news about: Acer Medical


Sep 02, 2025, 11:14 ET CorNeat Vision's Artificial Cornea Restores Perfect 20/20 Vision in Shingles-Blinded Eye

lives. At Beilinson's Ophthalmology Department, we are committed to leading with cutting-edge technologies, and this breakthrough reflects our mission to bring the future of eye care into the present." said Prof. Irit Bahar, Head of Ophthalmology, Beilinson Hospital

More news about: CorNeat Vision


Sep 02, 2025, 08:30 ET InMode to Present at Baird 2025 Global Healthcare Conference

technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com. Forward-Looking

More news about: InMode Ltd.


Sep 02, 2025, 08:00 ET ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions; marks new refractive and cataract milestones

Europe's leading refractive and cataract surgeons," says Magnus Reibenspiess, Head of Strategic Business Unit Ophthalmology at ZEISS Medical Technology. "From major industry milestones to new digital workflow solutions, our industry leadership shines bright, setting new

More news about: Carl Zeiss Meditec AG


Sep 02, 2025, 08:00 ET ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions; marks new refractive and cataract milestones

Europe's leading refractive and cataract surgeons," says Magnus Reibenspiess, Head of Strategic Business Unit Ophthalmology at ZEISS Medical Technology. "From major industry milestones to new digital workflow solutions, our industry leadership shines bright, setting new

More news about: Carl Zeiss Meditec AG


Sep 02, 2025, 07:30 ET EyeCool Therapeutics Appoints Dr. Vance Thompson to Board of Directors

School of Medicine. She is the Associate Editor for the Journal of Refractive Surgery, and on the editorial board of Ophthalmology. Dr. Henderson completed her ophthalmology residency at Harvard Medical School, Massachusetts Eye and Ear Infirmary. She graduated from

More news about: EyeCool Therapeutics, Inc.


Aug 29, 2025, 07:30 ET YD Bio Limited Announces Closing of Business Combination and Listing on the Nasdaq Global Market

laboratory, and a monitoring test for recurrent breast cancer, expected to launch as an LDT later this year.Stem Cell- and Exosome-Based Ophthalmology Therapies: In partnership with 3D Global Biotech, the Company is advancing corneal stem cell and exosome technologies for the treatment of ocular

More news about: YD Bio Limited


Aug 28, 2025, 12:52 ET What's Driving Dermatology Practice Sales in 2025 and the 2026 Outlook

the past two decades, private equity and MSO buyers have transformed the ownership landscape across specialties like dental, physical therapy, ophthalmology, and veterinary medicine. Now, dermatology is undergoing a similar shift and creating significant opportunities for those preparing for a dermatology

More news about: TUSK Practice Sales


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.